posted on 2025-05-05, 21:13authored byEdvaldo
Vasconcelos Soares Maciel, Jonathan Eisert, Verena Dederer, Aylin Berwanger, Stefan Knapp, Martin Empting, Sebastian Mathea, Henrik Jensen, Frederik Lermyte
Native
electrospray ionization mass spectrometry has become an
important method for the discovery and validation of noncovalent ligands
for therapeutic targets. As a label-free method combining high sensitivity
and chemical specificity, it is ideally suited for this application.
However, the performance of the method is severely impacted by the
presence of nonvolatile buffers and salts, and there is a risk of
ion suppression if a target protein is coincubated with multiple candidate
ligands. These factors, along with the fairly labor-intensive nature,
required operator skill, and limited throughput of most implementations,
represent significant obstacles to the widespread adoption of native
mass spectrometry-based ligand discovery. Here, we demonstrate the
combination of flow-induced dispersion analysis with native mass spectrometry
for screening of ligands for an E3 ligase and two kinases of pharmacological
relevance. Importantly, this approach avoids ion suppression and formation
of salt adducts without the need for offline desalting or buffer exchange,
and each multiplexed measurement of a sample consisting of a target
protein and a mixture of more than 20 candidate ligands took only
a few minutes. Because the method is largely automated, this screening
technology represents a potentially important step toward making native
mass spectrometry a mainstream biophysical technique in drug discovery.